Trials / Withdrawn
WithdrawnNCT03020563
Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether liposomal bupivacaine wound infiltration decreases pain scores and narcotic use when compared to bupivacaine alone after open reduction internal fixation of midshaft clavicle fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liposomal Bupivacaine | Liposomal Bupivacaine |
| DRUG | Bupivacaine | Bupivacaine |
Timeline
- Start date
- 2017-08-23
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2017-01-13
- Last updated
- 2018-10-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03020563. Inclusion in this directory is not an endorsement.